Brief Information of the Cell Line and Protein
Cell Line ID: CL000109 , COS-1
Synonyms
Cos-1
COS 1
Cos 1
COS1
Cos1
CV-1 in Origin Simian-1
Category Transformed cell line
Organism
Chlorocebus aethiops (Green monkey)
Cellosaurus ID
CVCL_0223
Protein ID: PT01650 , Alpha-2A adrenergic receptor
Gene Name ADRA2A
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID P08913
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000109  Protein ID: PT01650
 
Compound ID Compound Name Compound Formula
CP0503845
2-N-[[1-[4-bromo-2-(trifluoromethoxy)phenyl]sulfonylpiperidin-4-yl]methyl]-4-N,4-N-dimethylquinazoline-2,4-diamine
   Show/Hide
C23H25BrF3N5O3S
 1
1
IC50 = 5.6 nM
   TI
   LI
   LO
   TS
CP0871069
4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide hydrochloride
   Show/Hide
C25H30BrClF3N5O3S
 1
1
IC50 = 7.7 nM
   TI
   LI
   LO
   TS
CP0404808
4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide
   Show/Hide
C25H29BrF3N5O3S
 1
1
IC50 = 7.7 nM
   TI
   LI
   LO
   TS
CP0500756
4-bromo-N-[[4-[[[4-(dimethylamino)quinazolin-2-yl]amino]methyl]cyclohexyl]methyl]-2-(trifluoromethoxy)benzamide
   Show/Hide
C26H29BrF3N5O2
 1
1
IC50 = 9.9 nM
   TI
   LI
   LO
   TS
CP0404813
4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexyl}-2-trifluoromethoxy-benzenesulfonamide
   Show/Hide
C24H27BrF3N5O3S
 1
1
IC50 = 21 nM
   TI
   LI
   LO
   TS
CP0464467
2-N-[[4-[[[4-bromo-2-(trifluoromethoxy)phenyl]methylamino]methyl]cyclohexyl]methyl]-4-N,4-N-dimethylquinazoline-2,4-diamine
   Show/Hide
C26H31BrF3N5O
 1
1
IC50 = 31 nM
   TI
   LI
   LO
   TS
CP0494619
4-bromo-N-[[4-[[[4-(dimethylamino)quinazolin-2-yl]amino]methyl]cyclohexyl]methyl]-N-methyl-2-(trifluoromethoxy)benzenesulfonamide
   Show/Hide
C26H31BrF3N5O3S
 1
1
IC50 = 34 nM
   TI
   LI
   LO
   TS
CP0392533
2-N-[[4-[[[4-bromo-2-(trifluoromethoxy)phenyl]methyl-methylamino]methyl]cyclohexyl]methyl]-4-N,4-N-dimethylquinazoline-2,4-diamine
   Show/Hide
C27H33BrF3N5O
 1
1
IC50 = 44 nM
   TI
   LI
   LO
   TS
CP0475855
3,4-Dichloro-N-[4-(4-dimethylamino-quinazolin-2-ylamino)-cyclohexyl]-benzamide
   Show/Hide
C23H25Cl2N5O
 1
1
IC50 = 47 nM
   TI
   LI
   LO
   TS
CP0495240
4-Bromo-N-[4-(4-dimethylamino-quinazolin-2-ylamino)-cyclohexyl]-2-trifluoromethoxy-benzenesulfonamide
   Show/Hide
C23H25BrF3N5O3S
 1
1
IC50 = 47 nM
   TI
   LI
   LO
   TS
CP0392292
4-Bromo-N-[4-(4-dimethylamino-quinazolin-2-ylamino)-cyclohexyl]-2-trifluoromethoxy-benzenesulfonamide
   Show/Hide
C23H25BrF3N5O3S
 1
1
IC50 = 57 nM
   TI
   LI
   LO
   TS
CP0409351
4-Bromo-N-[4-(quinazolin-2-ylamino)-cyclohexyl]-2-trifluoromethoxy-benzenesulfonamide
   Show/Hide
C21H20BrF3N4O3S
 1
1
IC50 = 57 nM
   TI
   LI
   LO
   TS
CP0466919
Butane-1-sulfonic acid {4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-amide
   Show/Hide
C22H35N5O2S
 1
1
IC50 = 58 nM
   TI
   LI
   LO
   TS
CP0496862
N-[4-[[4-(dimethylamino)quinazolin-2-yl]amino]cyclohexyl]-3-(trifluoromethyl)benzamide
   Show/Hide
C24H26F3N5O
 1
1
IC50 = 60 nM
   TI
   LI
   LO
   TS
CP0449373
3-Bromo-N-[4-(4-dimethylamino-quinazolin-2-ylamino)-cyclohexyl]-benzamide
   Show/Hide
C23H26BrN5O
 1
1
IC50 = 63 nM
   TI
   LI
   LO
   TS
CP0497065
N-[4-[[4-(dimethylamino)quinazolin-2-yl]amino]cyclohexyl]-3,5-dimethoxybenzamide
   Show/Hide
C25H31N5O3
 1
1
IC50 = 71 nM
   TI
   LI
   LO
   TS
CP0431375
3-Chloro-N-[4-(4-dimethylamino-quinazolin-2-ylamino)-cyclohexyl]-benzamide
   Show/Hide
C23H26ClN5O
 1
1
IC50 = 76 nM
   TI
   LI
   LO
   TS
CP0493156
N-[[4-[[[4-(dimethylamino)quinazolin-2-yl]amino]methyl]cyclohexyl]methyl]methanesulfonamide
   Show/Hide
C19H29N5O2S
 1
1
IC50 = 86 nM
   TI
   LI
   LO
   TS
CP0424979
N-[4-[[4-(dimethylamino)quinazolin-2-yl]amino]cyclohexyl]-3-nitrobenzamide
   Show/Hide
C23H26N6O3
 1
1
IC50 = 97 nM
   TI
   LI
   LO
   TS
CP0039984
CGP 71683
   Show/Hide
C26H29N5O2S
 1
1
IC50 = 97 nM
   TI
   LI
   LO
   TS
CP0431012
N-[[4-[[(4-aminoquinazolin-2-yl)amino]methyl]cyclohexyl]methyl]-4-bromo-2-(trifluoromethoxy)benzenesulfonamide
   Show/Hide
C23H25BrF3N5O3S
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0404697
N-[4-[[4-(dimethylamino)quinazolin-2-yl]amino]cyclohexyl]-3-methylbenzamide
   Show/Hide
C24H29N5O
 1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0431015
4-Bromo-N-[4-(4-dimethylamino-quinazolin-2-ylamino)-cyclohexylmethyl]-2-trifluoromethoxy-benzenesulfonamide
   Show/Hide
C24H27BrF3N5O3S
 1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0378340
4-Bromo-N-[4-(4-dimethylamino-quinazolin-2-ylamino)-cyclohexylmethyl]-2-trifluoromethoxy-benzenesulfonamide
   Show/Hide
C24H27BrF3N5O3S
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0424928
N-[4-[[4-(dimethylamino)quinazolin-2-yl]amino]cyclohexyl]-3-fluorobenzamide
   Show/Hide
C23H26FN5O
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0409350
4-Bromo-N-[4-(quinazolin-2-ylamino)-cyclohexylmethyl]-2-trifluoromethoxy-benzenesulfonamide
   Show/Hide
C22H22BrF3N4O3S
 1
1
IC50 = 130 nM
   TI
   LI
   LO
   TS
CP0404811
4-Bromo-N-[4-(quinazolin-2-ylaminomethyl)-cyclohexylmethyl]-2-trifluoromethoxy-benzenesulfonamide
   Show/Hide
C23H24BrF3N4O3S
 1
1
IC50 = 140 nM
   TI
   LI
   LO
   TS
CP0378311
N-[4-[[4-(dimethylamino)quinazolin-2-yl]amino]cyclohexyl]-4-fluorobenzamide
   Show/Hide
C23H26FN5O
 1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0392541
3-Cyano-N-[4-(4-dimethylamino-quinazolin-2-ylamino)-cyclohexyl]-benzamide
   Show/Hide
C24H26N6O
 1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0379328
2-N-[4-[[4-bromo-2-(trifluoromethoxy)phenyl]methylamino]cyclohexyl]-4-N,4-N-dimethylquinazoline-2,4-diamine
   Show/Hide
C24H27BrF3N5O
 1
1
IC50 = 170 nM
   TI
   LI
   LO
   TS
CP0440289
2-N-[1-[4-bromo-2-(trifluoromethoxy)phenyl]sulfonylpiperidin-4-yl]-4-N,4-N-dimethylquinazoline-2,4-diamine
   Show/Hide
C22H23BrF3N5O3S
 1
1
IC50 = 170 nM
   TI
   LI
   LO
   TS
CP0480696
N-[4-[[4-(dimethylamino)quinazolin-2-yl]amino]cyclohexyl]-2,3,4-trifluorobenzamide
   Show/Hide
C23H24F3N5O
 1
1
IC50 = 200 nM
   TI
   LI
   LO
   TS
CP0043469
ATC0175
   Show/Hide
C23H25F2N5O
 1
1
IC50 = 260 nM
   TI
   LI
   LO
   TS
CP0431371
2-N-[4-[[[4-bromo-2-(trifluoromethoxy)phenyl]methylamino]methyl]cyclohexyl]-4-N,4-N-dimethylquinazoline-2,4-diamine
   Show/Hide
C25H29BrF3N5O
 1
1
IC50 = 360 nM
   TI
   LI
   LO
   TS
CP0392299
4-bromo-N-[4-[[4-(dimethylamino)quinazolin-2-yl]amino]cyclohexyl]-2-(trifluoromethoxy)benzamide
   Show/Hide
C24H25BrF3N5O2
 1
1
IC50 = 390 nM
   TI
   LI
   LO
   TS
CP0424935
2-N-[1-[[4-bromo-2-(trifluoromethoxy)phenyl]methyl]piperidin-4-yl]-4-N,4-N-dimethylquinazoline-2,4-diamine
   Show/Hide
C23H25BrF3N5O
 1
1
IC50 = 520 nM
   TI
   LI
   LO
   TS
CP0436964
4-bromo-N-[[4-[[4-(dimethylamino)quinazolin-2-yl]amino]cyclohexyl]methyl]-2-(trifluoromethoxy)benzamide
   Show/Hide
C25H27BrF3N5O2
 1
1
IC50 = 570 nM
   TI
   LI
   LO
   TS